Surviving Sepsis Campaign guidelines 2025 2026 updates

surviving sepsis campaign guidelines 2024 2025

mkdir -p /home/daytona/workspace/dnb-sepsis && ls /home/daytona/workspace/dnb-se…

~/dnb-sepsis/create_sepsis_doc.js

const {
  Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
  HeadingLevel, AlignmentType, BorderStyle, WidthType, ShadingType,
  LevelFormat, VerticalAlign
} = require('docx');
const fs = require('fs');

// Numbering config for bullets
const numberingConfig = [
  {
    reference: "bullets",
    levels: [{
      level: 0, format: LevelFormat.BULLET, text: "\u2022",
      alignment: AlignmentType.LEFT,
      style: {
        paragraph: { indent: { left: 720, hanging: 360 } },
        run: { font: "Arial", size: 24 }
      }
    }, {
      level: 1, format: LevelFormat.BULLET, text: "\u25E6",
      alignment: AlignmentType.LEFT,
      style: {
        paragraph: { indent: { left: 1080, hanging: 360 } },
        run: { font: "Arial", size: 22 }
      }
    }]
  },
  {
    reference: "numbered",
    levels: [{
      level: 0, format: LevelFormat.DECIMAL, text: "%1.",
      alignment: AlignmentType.LEFT,
      style: {
        paragraph: { indent: { left: 720, hanging: 360 } },
        run: { font: "Arial", size: 24 }
      }
    }]
  }
];

function h1(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_1,
    children: [new TextRun({ text, bold: true, font: "Arial", size: 32, color: "1F3864" })],
    spacing: { before: 300, after: 120 }
  });
}

function h2(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_2,
    children: [new TextRun({ text, bold: true, font: "Arial", size: 28, color: "2E74B5" })],
    spacing: { before: 240, after: 80 }
  });
}

function h3(text) {
  return new Paragraph({
    children: [new TextRun({ text, bold: true, underline: {}, font: "Arial", size: 24, color: "2E74B5" })],
    spacing: { before: 160, after: 60 }
  });
}

function para(text) {
  return new Paragraph({
    children: [new TextRun({ text, font: "Arial", size: 24 })],
    spacing: { before: 60, after: 60 },
    alignment: AlignmentType.JUSTIFIED
  });
}

function bullet(text, level = 0) {
  return new Paragraph({
    numbering: { reference: "bullets", level },
    children: [new TextRun({ text, font: "Arial", size: 24 })],
    spacing: { before: 40, after: 40 }
  });
}

function boldBullet(label, text, level = 0) {
  return new Paragraph({
    numbering: { reference: "bullets", level },
    children: [
      new TextRun({ text: label, bold: true, font: "Arial", size: 24 }),
      new TextRun({ text: text, font: "Arial", size: 24 })
    ],
    spacing: { before: 40, after: 40 }
  });
}

function divider() {
  return new Paragraph({
    children: [new TextRun({ text: "" })],
    border: { bottom: { style: BorderStyle.SINGLE, size: 6, color: "2E74B5" } },
    spacing: { before: 120, after: 120 }
  });
}

function makeTable(headers, rows) {
  const headerCells = headers.map(h =>
    new TableCell({
      children: [new Paragraph({
        children: [new TextRun({ text: h, bold: true, font: "Arial", size: 22, color: "FFFFFF" })],
        alignment: AlignmentType.CENTER
      })],
      shading: { fill: "1F3864", type: ShadingType.SOLID },
      verticalAlign: VerticalAlign.CENTER
    })
  );

  const tableRows = [new TableRow({ children: headerCells, tableHeader: true })];

  rows.forEach((row, rowIdx) => {
    const cells = row.map(cell =>
      new TableCell({
        children: [new Paragraph({
          children: [new TextRun({ text: cell, font: "Arial", size: 22 })],
          alignment: AlignmentType.LEFT
        })],
        shading: rowIdx % 2 === 0
          ? { fill: "EBF3FB", type: ShadingType.SOLID }
          : { fill: "FFFFFF", type: ShadingType.SOLID },
        verticalAlign: VerticalAlign.CENTER
      })
    );
    tableRows.push(new TableRow({ children: cells }));
  });

  return new Table({
    rows: tableRows,
    width: { size: 100, type: WidthType.PERCENTAGE }
  });
}

const doc = new Document({
  numbering: { config: numberingConfig },
  styles: {
    default: { document: { run: { font: "Arial", size: 24 } } },
    paragraphStyles: [
      {
        id: "Heading1", name: "Heading 1", basedOn: "Normal", next: "Normal", quickFormat: true,
        run: { size: 32, bold: true, font: "Arial", color: "1F3864" },
        paragraph: { spacing: { before: 300, after: 120 }, outlineLevel: 0 }
      },
      {
        id: "Heading2", name: "Heading 2", basedOn: "Normal", next: "Normal", quickFormat: true,
        run: { size: 28, bold: true, font: "Arial", color: "2E74B5" },
        paragraph: { spacing: { before: 240, after: 80 }, outlineLevel: 1 }
      }
    ]
  },
  sections: [{
    properties: {
      page: {
        size: { width: 11906, height: 16838 },
        margin: { top: 1134, right: 1134, bottom: 1134, left: 1134 }
      }
    },
    children: [

      // ─── TITLE BLOCK ───
      new Paragraph({
        children: [new TextRun({ text: "SURVIVING SEPSIS CAMPAIGN GUIDELINES", bold: true, font: "Arial", size: 40, color: "1F3864" })],
        alignment: AlignmentType.CENTER,
        spacing: { before: 0, after: 100 }
      }),
      new Paragraph({
        children: [new TextRun({ text: "2021 Guidelines & 2025–2026 Updates", bold: true, font: "Arial", size: 28, color: "2E74B5" })],
        alignment: AlignmentType.CENTER,
        spacing: { before: 0, after: 60 }
      }),
      new Paragraph({
        children: [new TextRun({ text: "DNB Anaesthesia Examination — 10 Marks Answer", font: "Arial", size: 24, italics: true, color: "595959" })],
        alignment: AlignmentType.CENTER,
        spacing: { before: 0, after: 60 }
      }),
      new Paragraph({
        children: [new TextRun({ text: "Exam Focus: Critical Care | Sepsis & Septic Shock | Evidence-Based Management", font: "Arial", size: 22, italics: true, color: "595959" })],
        alignment: AlignmentType.CENTER,
        spacing: { before: 0, after: 180 }
      }),
      divider(),

      // ─── 1. INTRODUCTION ───
      h1("1. Introduction"),
      para("Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection (Sepsis-3, 2016). Septic shock is a subset characterized by circulatory, cellular, and metabolic abnormalities sufficient to substantially increase mortality. The Surviving Sepsis Campaign (SSC), a collaborative initiative between the European Society of Intensive Care Medicine (ESICM) and the Society of Critical Care Medicine (SCCM), was launched in 2002 with the primary aim of reducing mortality from sepsis worldwide."),
      para("Guidelines were first published in 2004 and subsequently revised in 2008, 2012, 2016, and most comprehensively in 2021. The current framework for 2025–2026 incorporates updates from recent large-scale RCTs, meta-analyses, and evolving clinical evidence."),
      divider(),

      // ─── 2. DEFINITIONS (Sepsis-3) ───
      h1("2. Definitions — Sepsis-3 Criteria"),

      makeTable(
        ["Condition", "Definition / Criteria"],
        [
          ["Infection", "Suspected or documented infection"],
          ["Sepsis", "Infection + SOFA score ≥2 from baseline (organ dysfunction)"],
          ["Septic Shock", "Sepsis + vasopressor need to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation"],
          ["qSOFA (screening)", "≥2 of: RR ≥22/min, GCS <15, SBP ≤100 mmHg — indicates high risk"],
          ["SOFA score", "Assesses 6 organ systems: respiratory, coagulation, liver, cardiovascular, CNS, renal"]
        ]
      ),
      new Paragraph({ children: [new TextRun("")], spacing: { before: 120, after: 0 } }),
      divider(),

      // ─── 3. THE HOUR-1 BUNDLE ───
      h1("3. The Hour-1 Bundle"),
      para("The SSC 2018 update replaced the 3-hour and 6-hour bundles with a single Hour-1 Bundle (re-affirmed in 2021 and 2025). The emphasis is on treating sepsis as a medical emergency analogous to trauma or acute MI."),

      makeTable(
        ["Action", "Target / Detail"],
        [
          ["1. Measure lactate", "Remeasure if initial lactate >2 mmol/L; guides resuscitation adequacy"],
          ["2. Blood cultures", "Obtain before antibiotics (do NOT delay antibiotics to obtain cultures)"],
          ["3. Broad-spectrum antibiotics", "Within 1 hour of recognition of septic shock or high-likelihood sepsis"],
          ["4. IV Crystalloid", "30 mL/kg crystalloid within first 3 hours for hypotension or lactate ≥4 mmol/L"],
          ["5. Vasopressors", "Start if MAP <65 mmHg despite fluids; Norepinephrine is first-line"],
        ]
      ),
      new Paragraph({ children: [new TextRun("")], spacing: { before: 120, after: 0 } }),
      divider(),

      // ─── 4. ANTIMICROBIAL THERAPY ───
      h1("4. Antimicrobial Therapy"),

      h2("A. Timing"),
      bullet("Septic shock: Empiric antibiotics within 1 hour of recognition"),
      bullet("Sepsis without shock: Antibiotics within 3 hours if alternative diagnosis not identified"),
      bullet("Each 1-hour delay in appropriate antibiotics in septic shock → ~7–8% increase in mortality"),

      h2("B. Selection Principles"),
      bullet("Broad-spectrum empiric antibiotics covering all likely pathogens"),
      bullet("Consider: site of infection, community vs. healthcare exposure, prior cultures, local resistance patterns, immune status"),
      boldBullet("No Pseudomonas risk: ", "3rd-generation cephalosporin (ceftriaxone, cefotaxime)"),
      boldBullet("Pseudomonas likely: ", "Cefepime, piperacillin-tazobactam, or carbapenem (meropenem, imipenem)"),
      boldBullet("MRSA risk factors: ", "Add vancomycin or linezolid"),
      boldBullet("Antifungal: ", "Echinocandin if high-risk (recent abdominal surgery, Candida colonization, TPN, liver failure)"),

      h2("C. De-escalation"),
      bullet("Reassess antibiotic appropriateness daily"),
      bullet("Procalcitonin levels may guide de-escalation (NOT initiation)"),
      bullet("Target shortest effective duration; most cases: 7–10 days"),
      divider(),

      // ─── 5. FLUID RESUSCITATION ───
      h1("5. Fluid Resuscitation"),
      bullet("Initial fluid bolus: 30 mL/kg balanced crystalloid (e.g., Plasmalyte, Hartmann's) in first 3 hours"),
      bullet("Balanced crystalloids preferred over 0.9% normal saline (reduces risk of hyperchloremic acidosis, AKI)"),
      bullet("Albumin: Consider adding when large volumes of crystalloid required (4% or 5% albumin)"),
      bullet("Avoid hetastarch (HES) — increases mortality and AKI"),
      bullet("Beyond initial resuscitation: Guide further fluids with dynamic assessments — pulse pressure variation (PPV), stroke volume variation (SVV), or passive leg raise (PLR) test"),
      bullet("Serial lactate measurements: Use to assess adequacy of resuscitation (target lactate clearance ≥10–20% in 2 hours)"),
      bullet("Avoid fluid overload — associated with worse outcomes; reassess frequently"),
      divider(),

      // ─── 6. VASOPRESSORS ───
      h1("6. Vasopressor & Cardiovascular Support"),

      makeTable(
        ["Agent", "Role", "Dose / Notes"],
        [
          ["Norepinephrine", "1st-line vasopressor", "Start early; target MAP ≥65 mmHg"],
          ["Vasopressin", "2nd-line (add-on)", "0.03 U/min fixed rate; add when NE dose ≥0.25–0.5 µg/kg/min; spares NE"],
          ["Epinephrine", "3rd-line / adjunct", "When hypotension persists despite NE + vasopressin"],
          ["Dopamine", "Avoid generally", "Only in highly selected cases (bradycardia with low CO)"],
          ["Dobutamine", "Low CO states", "Add to NE or use epinephrine alone for cardiogenic component"],
          ["Terlipressin / Levosimendan", "NOT recommended", "Insufficient evidence for routine use"],
        ]
      ),
      new Paragraph({ children: [new TextRun("")], spacing: { before: 120, after: 0 } }),
      para("MAP target: ≥65 mmHg (higher targets 80–85 mmHg not shown to improve outcomes except in chronic hypertensives)"),
      para("Corticosteroids (IV Hydrocortisone 200 mg/day): Recommended when shock persists despite adequate fluids and vasopressors. Reduces vasopressor duration but mortality benefit is modest."),
      divider(),

      // ─── 7. MECHANICAL VENTILATION & RESPIRATORY SUPPORT ───
      h1("7. Mechanical Ventilation & Respiratory Support"),

      h2("Lung Protective Ventilation (Sepsis-induced ARDS)"),
      bullet("Tidal volume (VT): 6 mL/kg predicted body weight (PBW)"),
      bullet("Plateau pressure: ≤30 cmH₂O"),
      bullet("Driving pressure: Target <15 cmH₂O"),
      bullet("PEEP: Titrate using FiO₂/PEEP tables; higher PEEP for moderate-severe ARDS"),
      bullet("Target SpO₂: 92–96% (avoid hyperoxia — worsens outcomes)"),

      h2("Prone Positioning"),
      bullet("Moderate-severe ARDS (PaO₂:FiO₂ ratio <150 mmHg on FiO₂ ≥0.6, PEEP ≥5 cmH₂O)"),
      bullet("Prone for ≥12 hours per day — reduces mortality (PROSEVA trial)"),
      bullet("Neuromuscular blockade facilitates prone positioning; intermittent bolus preferred over continuous infusion"),

      h2("Other Ventilation Strategies"),
      bullet("HFOV (High-Frequency Oscillatory Ventilation): NOT recommended"),
      bullet("Recruitment maneuvers: Not routinely recommended (evidence mixed)"),
      bullet("vvECMO: Suggested for severe ARDS failing conventional MV (in experienced centers)"),
      bullet("Sedation: Minimize; use SAT/SBT protocols; target RASS −1 to −2"),
      bullet("Elevate head of bed 30–45° (VAP prevention)"),
      divider(),

      // ─── 8. OTHER SUPPORTIVE CARE ───
      h1("8. Additional Supportive Care Measures"),

      h2("Glucose Control"),
      bullet("Target blood glucose 140–180 mg/dL (7.8–10 mmol/L)"),
      bullet("Intensive insulin therapy (<110 mg/dL) is harmful — increases hypoglycemia risk"),

      h2("Renal Replacement Therapy (RRT)"),
      bullet("Initiate RRT for AKI with life-threatening fluid, electrolyte, or acid-base disturbances"),
      bullet("CRRT (continuous) and IHD (intermittent) are equivalent in outcome"),
      bullet("No benefit to early prophylactic RRT"),
      bullet("Bicarbonate: Use for arterial pH <7.2 in setting of AKI (buffer therapy)"),

      h2("Blood Transfusion"),
      bullet("Target hemoglobin 7–9 g/dL in absence of tissue hypoperfusion, coronary artery disease, or active hemorrhage"),
      bullet("Restrictive transfusion strategy is recommended"),

      h2("DVT Prophylaxis"),
      bullet("Pharmacological prophylaxis (LMWH preferred over UFH) unless contraindicated"),
      bullet("Mechanical prophylaxis (compression stockings / IPC) when pharmacological prophylaxis is contraindicated"),

      h2("Stress Ulcer Prophylaxis"),
      bullet("Recommended in patients with sepsis who have risk factors for GI bleeding"),
      bullet("PPIs preferred over H₂ antagonists"),

      h2("Nutrition"),
      bullet("Early enteral nutrition preferred over parenteral (start within 48 hours)"),
      bullet("Avoid overfeeding; target normocaloric goals initially"),
      bullet("Parenteral nutrition only when enteral route is not feasible"),

      h2("Goals of Care"),
      bullet("Discuss prognosis, goals of care, and advance care planning with patient and family"),
      bullet("Integrate palliative care principles early in critically ill sepsis patients"),
      bullet("Discharge planning: Screen for economic/social support; establish follow-up for post-intensive care syndrome (PICS)"),
      divider(),

      // ─── 9. SOURCE CONTROL ───
      h1("9. Source Control"),
      bullet("Identify source of infection as rapidly as possible (ideally within 6–12 hours of presentation)"),
      bullet("Common sources: Intra-abdominal abscess, bowel perforation, pyelonephritis, cholangitis, necrotizing fasciitis"),
      bullet("Intervene with the least invasive effective method (percutaneous drainage preferred over open surgery when feasible)"),
      bullet("Remove infected indwelling devices (central lines, urinary catheters) promptly"),
      bullet("Source control should not delay antimicrobials — both must proceed simultaneously"),
      divider(),

      // ─── 10. INVESTIGATIONS ───
      h1("10. Investigations & Monitoring"),

      makeTable(
        ["Investigation", "Purpose"],
        [
          ["Blood cultures (×2, peripheral + central)", "Before antibiotics; identify causative organism"],
          ["Serum lactate", "Tissue hypoperfusion marker; guide resuscitation"],
          ["Procalcitonin (PCT)", "Guide antibiotic de-escalation (NOT initiation)"],
          ["CBC, CMP, coagulation profile", "Organ dysfunction assessment"],
          ["Urinalysis + urine culture", "Urinary source identification"],
          ["CXR / CT scan", "Identify pulmonary source / abscesses"],
          ["ABG with co-oximetry", "Oxygenation and ventilation status"],
          ["SOFA score (serial)", "Track organ dysfunction trajectory"],
          ["Echocardiography (TTE/TEE)", "Cardiac function, guide fluid and vasopressor therapy"],
          ["Hemodynamic monitoring", "CVP, CO, SVR — guide resuscitation in ICU"],
        ]
      ),
      new Paragraph({ children: [new TextRun("")], spacing: { before: 120, after: 0 } }),
      divider(),

      // ─── 11. 2025-26 UPDATES ───
      h1("11. Key Updates (2024–2026)"),

      para("While a formal 2026 SSC guideline document has not been independently published as of May 2026, the following updates reflect evolving evidence incorporated into current practice:"),

      h2("Fluid Strategy"),
      bullet("CLASSIC trial evidence: Restrictive vs. standard fluid approaches in ICU — restrictive strategy acceptable in resuscitated patients; avoid routine liberal fluids"),
      bullet("Albumin use in large-volume resuscitation reaffirmed"),

      h2("Vasopressor Timing"),
      bullet("CLOVERS and CLASSIC trials: Earlier vasopressor use with less fluid — improved outcomes; supports earlier NE initiation"),
      bullet("Angiotensin II (GIAOUR trial): Emerging role as rescue vasopressor in catecholamine-refractory septic shock"),

      h2("Vitamin C and Thiamine"),
      bullet("VICTAS, VITAMINS, LOVIT trials: IV Vitamin C (1.5g q6h) + thiamine + hydrocortisone showed NO mortality benefit in RCTs despite early promising data"),
      bullet("Vitamin C monotherapy: Not recommended"),

      h2("Antibiotic Stewardship"),
      bullet("De-escalation based on culture results and PCT-guided therapy — strongly endorsed"),
      bullet("Beta-lactam prolonged infusion: Pharmacokinetic/pharmacodynamic optimization is recommended (particularly for Pseudomonas, ESBL)"),

      h2("Glycocalyx & Endothelial Protection"),
      bullet("Emerging research: Endothelial glycocalyx damage contributes to capillary leak; therapeutic targets under investigation"),

      h2("Sepsis Screening Technology"),
      bullet("AI-driven early warning systems (e.g., TREWS, Epic Sepsis Model) evaluated; SSC still does not preferentially endorse any single screening tool"),

      h2("Post-Sepsis Syndrome"),
      bullet("Growing recognition of PICS (Post-Intensive Care Syndrome): Cognitive, psychological, and physical disability after surviving sepsis"),
      bullet("Follow-up clinics and rehabilitation recommended in discharge planning"),
      divider(),

      // ─── 12. SUMMARY TABLE ───
      h1("12. Quick Revision — Summary Table"),

      makeTable(
        ["Domain", "Key Recommendation (SSC 2021 / 2025–26)"],
        [
          ["Recognition", "SOFA ≥2 (sepsis); vasopressors + lactate >2 mmol/L (septic shock); qSOFA for screening"],
          ["Hour-1 Bundle", "Cultures → Antibiotics → Lactate → Fluid → Vasopressors"],
          ["Antibiotics", "Within 1h (shock) / 3h (sepsis without shock); broad-spectrum; de-escalate guided by PCT/cultures"],
          ["Fluid", "30 mL/kg balanced crystalloid; avoid HES; add albumin for large volumes; dynamic assessment for further fluids"],
          ["Vasopressors", "NE first-line; vasopressin add-on; epinephrine 3rd; hydrocortisone 200 mg/day for refractory shock"],
          ["Ventilation", "VT 6 mL/kg PBW, plateau ≤30 cmH₂O; prone ≥12h for severe ARDS"],
          ["Glucose", "140–180 mg/dL; avoid tight glycemic control"],
          ["Transfusion", "Hb target 7–9 g/dL (restrictive strategy)"],
          ["Source Control", "Identify and control within 6–12h; remove infected devices"],
          ["RRT", "For life-threatening AKI complications; CRRT = IHD in outcomes"],
          ["Nutrition", "Early enteral nutrition within 48h; avoid overfeeding"],
          ["Goals of Care", "Early palliative care integration; PICS screening at discharge"],
        ]
      ),
      new Paragraph({ children: [new TextRun("")], spacing: { before: 120, after: 0 } }),
      divider(),

      // ─── FOOTER NOTE ───
      new Paragraph({
        children: [new TextRun({ text: "References: Miller's Anesthesia 10e; Barash Clinical Anesthesia 9e; Harrison's Principles of Internal Medicine 22e (2025); Bailey & Love's Short Practice of Surgery 28e; SSC 2021 Guidelines (Evans et al., Crit Care Med 2021); German S3 Sepsis Guideline Update 2025 (Brunkhorst et al.)", font: "Arial", size: 18, italics: true, color: "595959" })],
        alignment: AlignmentType.JUSTIFIED,
        spacing: { before: 120, after: 60 }
      }),

    ]
  }]
});

Packer.toBuffer(doc).then(buffer => {
  fs.writeFileSync('/home/daytona/workspace/dnb-sepsis/Surviving_Sepsis_Guidelines_DNB_Anaesthesia.docx', buffer);
  console.log('Document created successfully!');
}).catch(err => {
  console.error('Error:', err);
  process.exit(1);
});

cd /home/daytona/workspace/dnb-sepsis && node create_sepsis_doc.js

python3 /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/works…

cd /home/daytona/workspace/dnb-sepsis && python3 -c " import zipfile, os with zi…